BetterLife Pharma BETRF
OTC BETRF
$0.24 -0.02 (-9.23%)
As of: Aug 21, 2026 · 2:48 PM EDT

BetterLife Pharma (BETRF) Depreciation & Amortization - Total (2021 - 2022)

BetterLife Pharma (BETRF) posted quarterly Depreciation & Amortization - Total of $3470.1 for Q4 2022, down 5.35% year-over-year from $3666.2 in Q4 2021, and down 3.17% quarter-over-quarter from $3583.6 in Q3 2022.

BetterLife Pharma (BETRF) Depreciation & Amortization - Total (2021 - 2022) Analysis & Trends

BetterLife Pharma's Depreciation & Amortization - Total history runs 2 years deep, the most recent figure standing at $3470.1 for Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 BetterLife Pharma 36.45 Mn 36.42 Mn - -

Historic Data

Download Data
DateValue
Oct 31, 2022 3,470.10
Jul 31, 2022 3,583.62
Apr 30, 2022 3,639.06
Oct 31, 2021 3,666.17
Jul 31, 2021 3,751.65
Apr 30, 2021 3,660.92